# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Jun 9, 2026

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2026-06-09
- Accepted by EDGAR: Jun 9, 2026, 16:05 ET
- Period: 2026-06-05
- Accession: 0001628280-26-041883
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000162828026041883/arqt-20260605.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000162828026041883/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000162828026041883/arqt-20260605.htm

Filed Jun 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-041883. Last ingested by Listed: Nov 2, 2026, 20:20 ET. No prices; not investment advice.